229
Views
56
CrossRef citations to date
0
Altmetric
Research Article

Praziquantel-loaded PLGA nanoparticles: preparation and characterization

&
Pages 13-24 | Received 04 Jan 2004, Accepted 10 Oct 2004, Published online: 03 Oct 2008

References

  • Allemann E, Leroux JC, Gurny R. 1998. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Advanced Drug Delivery Reviews 34:171–189.
  • Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews 28:5–24.
  • Becket G, Schep U, Tan MY. 1999. Improvement of the in vitro dissolution of praziquantel by complexation with a-, p- and y-ciclodextrins. International Journal of Pharmaceutics 179:65–71.
  • Binrbaum DT, Kosmala JD, Henthorn DB, Brannon-Peppas L. 2000. Controlled release of /3-estardiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. Journal of Controlled Release 65:375–387.
  • Brannon-Peppas L. 1995. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. International Journal of Pharmaceutics 116:1–9.
  • Burkersroda FV, Schedl L, Göpferich A. 2002. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 23:221–231.
  • Chorny M, Fishbein I, Danenberg HD, Golomb G. 2002. Lipophilic drug loaded nanospheres prepared by nanoparecipitation: effect of formulating variables on size, drug recovery and release kinetics. Journal of Controlled Release 83:389–400.
  • El-Arini SK, Leuenberger H. 1998. Dissolution properties of praziquantel-PVP systems. Pharmaceutica Acta Helvitae 73:89–94.
  • Feng S, Huang G. 2002. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. Journal of Controlled Release 71:53–69.
  • Freytag T, Dashevsky A, Tillman L, Hardee GE, Bodmeier R. 2000. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. Journal of Controlled Release 69:197–207.
  • Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. 1999. Lidocaine-loaded biodegradable nanospheres I. Optimization of the drug incorporation into the polymer matrix. Journal of Controlled Release 57:59–68.
  • Hans ML, Lowman AM. 2002. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Science 6:319–327.
  • Jain RA. 2000. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 21:2475–2490.
  • Jeon HJ, Jeong YL,, Jang MK, Park YH, Nab JW. 2000. Effect of solvent on the preparation of surfactant-free poly (D,L-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. International Journal of Pharmaceutics 207:99–108.
  • Mainardes R1\4, Silva LP. 2004. Drug delivery systems: past, present and future. Current Drug Targets 5:389-406. Mu L, Feng SS. 2002. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique forfabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). Journal of Controlled Release80:129–144.
  • Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews 55:329–347.
  • Park TG. 1995. Degradation of poly (lactide-co-glycolide acid) microspheres: effect of copolymer composition. Biomaterials 16:1123–1130.
  • Sah H. 1997. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on characteristics of PLGA microspheres. Journal of Controlled Release 47:233–245.
  • Sahoo SK, Panyam J, Prabha S, Labhasetwar V. 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release 82:105–114.
  • Schepmann D, Blaschke G. 2001. Isolation and identification of 8-hydroxypraziquantel as a metabolite of the antischistosomal drug praziquantel. Journal of Pharmaceutical and Biomedical Analysis 26:791-799. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticlesas drug delivery devices. Journal of Controlled Release 70:1–20.
  • Uhrich KE, Cannizzaro SM, Langer RS, Shakeshelf KM. 1999. Polymeric systems for controlled drug release. Chemical Reviews 99:3181–3198.
  • Vandervoort J, Ludwig A. 2002. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. International Journal of Pharmaceutics 238:77–92.
  • Vert M, Schwach G, Engel R, Coudane J. 1998. Something new in the field of PLA/GA bioresorbable polymers? Journal of Controlled Release 53:85–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.